179 related articles for article (PubMed ID: 32758567)
1. Molecular mechanisms of bufadienolides and their novel strategies for cancer treatment.
Deng LJ; Li Y; Qi M; Liu JS; Wang S; Hu LJ; Lei YH; Jiang RW; Chen WM; Qi Q; Tian HY; Han WL; Wu BJ; Chen JX; Ye WC; Zhang DM
Eur J Pharmacol; 2020 Nov; 887():173379. PubMed ID: 32758567
[TBL] [Abstract][Full Text] [Related]
2. Fibroblast Activation Protein α Activated Tripeptide Bufadienolide Antitumor Prodrug with Reduced Cardiotoxicity.
Deng LJ; Wang LH; Peng CK; Li YB; Huang MH; Chen MF; Lei XP; Qi M; Cen Y; Ye WC; Zhang DM; Chen WM
J Med Chem; 2017 Jul; 60(13):5320-5333. PubMed ID: 28595013
[TBL] [Abstract][Full Text] [Related]
3. Bufadienolides from amphibians: A promising source of anticancer prototypes for radical innovation, apoptosis triggering and Na
Sousa LQ; Machado KD; Oliveira SF; Araújo LD; Monção-Filho ED; Melo-Cavalcante AA; Vieira-Júnior GM; Ferreira PM
Toxicon; 2017 Mar; 127():63-76. PubMed ID: 28069354
[TBL] [Abstract][Full Text] [Related]
4. New bufadienolides extracted from Rhinella marina inhibit Na,K-ATPase and induce apoptosis by activating caspases 3 and 9 in human breast and ovarian cancer cells.
Garcia IJP; de Oliveira GC; de Moura Valadares JM; Banfi FF; Andrade SN; Freitas TR; Dos Santos Monção Filho E; Lima Santos H; Júnior GMV; Chaves MH; de Jesus Rodrigues D; Sanchez BAM; Varotti FP; Barbosa LA
Steroids; 2019 Dec; 152():108490. PubMed ID: 31499071
[TBL] [Abstract][Full Text] [Related]
5. Improved antitumor efficacy and reduced toxicity of liposomes containing bufadienolides.
Hu K; Zhu L; Liang H; Hu F; Feng J
Arch Pharm Res; 2011 Sep; 34(9):1487-94. PubMed ID: 21975810
[TBL] [Abstract][Full Text] [Related]
6. Novel Strategies for Solubility and Bioavailability Enhancement of Bufadienolides.
Shao H; Li B; Li H; Gao L; Zhang C; Sheng H; Zhu L
Molecules; 2021 Dec; 27(1):. PubMed ID: 35011278
[TBL] [Abstract][Full Text] [Related]
7. Conformational states of the pig kidney Na
Azalim P; do Monte FM; Rendeiro MM; Liu X; O'Doherty GA; Fontes CF; Leitão SG; Quintas LEM; Noël F
Biochem Pharmacol; 2020 Jan; 171():113679. PubMed ID: 31669257
[TBL] [Abstract][Full Text] [Related]
8. Cytochrome P450 Mining for Bufadienolide Diversification.
Lei X; Wang X; Xiong W; Xiao H; Wu Y; Huang T; Liang R; Li Y; Lin S
ACS Chem Biol; 2024 May; 19(5):1169-1179. PubMed ID: 38624108
[TBL] [Abstract][Full Text] [Related]
9. Molecular structure-affinity relationship of bufadienolides and human serum albumin in vitro and molecular docking analysis.
Zhou J; Lu G; Wang H; Zhang J; Duan J; Ma H; Wu Q
PLoS One; 2015; 10(5):e0126669. PubMed ID: 25946161
[TBL] [Abstract][Full Text] [Related]
10. Increasing the anticancer performance of bufalin (BUF) by introducing an endosome-escaping polymer and tumor-targeting peptide in the design of a polymeric prodrug.
Shi XJ; Qiu YY; Yu H; Liu C; Yuan YX; Yin PH; Liu T
Colloids Surf B Biointerfaces; 2018 Jun; 166():224-234. PubMed ID: 29602078
[TBL] [Abstract][Full Text] [Related]
11. Application of highly efficient and lowly toxic bufadienolides screened from toad skin in lymphatic chemotherapy for colorectal cancer through a lymphatic metastatic model.
He C; Zou Z; Xia S; Xing X; Hu S; Hu Z; Li Y; Li S; Zhang H; Yang Y; Liu Y; Xu X; Liu B; Wang Y; Xu Y; Du X
Int Immunopharmacol; 2019 May; 70():241-251. PubMed ID: 30851704
[TBL] [Abstract][Full Text] [Related]
12. Three bufadienolides induce cell death in the human lung cancer cell line CL1-5 mainly through autophagy.
Huang HC; Chang WT; Lee MS; Chen HY; Chen YH; Lin CC; Lin MK
Bioorg Med Chem Lett; 2021 Jan; 31():127715. PubMed ID: 33246109
[TBL] [Abstract][Full Text] [Related]
13. A bufadienolide-loaded submicron emulsion for oral administration: stability, antitumor efficacy and toxicity.
Li W; Lin X; Yang Z; Zhang W; Ren T; Qu F; Wang Y; Zhang N; Tang X
Int J Pharm; 2015 Feb; 479(1):52-62. PubMed ID: 25545797
[TBL] [Abstract][Full Text] [Related]
14. Microbial transformation of three bufadienolides by Nocardia sp. and some insight for the cytotoxic structure-activity relationship (SAR).
Zhang J; Sun Y; Liu JH; Yu BY; Xu Q
Bioorg Med Chem Lett; 2007 Nov; 17(22):6062-5. PubMed ID: 17911017
[TBL] [Abstract][Full Text] [Related]
15. A new bufadienolide with cytotoxic activity from the Chinese traditional drug Ch'an Su.
Xu R; Xie HQ; Deng LL; Zhang JX; Yang FM; Liu JH; Hao XJ; Zhang YH
Chin J Nat Med; 2014 Aug; 12(8):623-7. PubMed ID: 25156289
[TBL] [Abstract][Full Text] [Related]
16. Endogenous and exogenous cardiac glycosides: their roles in hypertension, salt metabolism, and cell growth.
Schoner W; Scheiner-Bobis G
Am J Physiol Cell Physiol; 2007 Aug; 293(2):C509-36. PubMed ID: 17494630
[TBL] [Abstract][Full Text] [Related]
17. Anti-tumor activity and apoptosis-regulation mechanisms of bufalin in various cancers: new hope for cancer patients.
Yin PH; Liu X; Qiu YY; Cai JF; Qin JM; Zhu HR; Li Q
Asian Pac J Cancer Prev; 2012; 13(11):5339-43. PubMed ID: 23317181
[TBL] [Abstract][Full Text] [Related]
18. Anti-tumor effects and 3D-quantitative structure-activity relationship analysis of bufadienolides from toad venom.
Liu JS; Deng LJ; Tian HY; Ruan ZX; Cao HH; Ye WC; Zhang DM; Yu ZL
Fitoterapia; 2019 Apr; 134():362-371. PubMed ID: 30872126
[TBL] [Abstract][Full Text] [Related]
19. Proteasome Inhibition Contributed to the Cytotoxicity of Arenobufagin after Its Binding with Na, K-ATPase in Human Cervical Carcinoma HeLa Cells.
Yue Q; Zhen H; Huang M; Zheng X; Feng L; Jiang B; Yang M; Wu W; Liu X; Guo D
PLoS One; 2016; 11(7):e0159034. PubMed ID: 27428326
[TBL] [Abstract][Full Text] [Related]
20. Strategies on the development of small molecule anticancer drugs for targeted therapy.
Lu YH; Gao XQ; Wu M; Zhang-Negrerie D; Gao Q
Mini Rev Med Chem; 2011 Jun; 11(7):611-24. PubMed ID: 21699492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
